Β-LGND2
Β-LGND2 is a protein that in humans is encoded by the LGND2 gene. It is also known as Liver-expressed antimicrobial peptide 2 (LEAP2). This protein is a part of the antimicrobial peptide family, which are small proteins involved in the innate immune response.
Function[edit | edit source]
Β-LGND2 is a secreted protein that is primarily expressed in the liver. It has been found to have antimicrobial activity against a variety of bacteria, including Gram-negative and Gram-positive species. The protein is thought to function by disrupting the bacterial cell membrane, leading to cell death.
In addition to its antimicrobial activity, Β-LGND2 has been found to play a role in the regulation of energy homeostasis. It acts as a natural antagonist for the ghrelin receptor, a G-protein coupled receptor that is involved in the regulation of appetite and energy balance.
Clinical significance[edit | edit source]
Alterations in the expression of Β-LGND2 have been associated with a variety of diseases. For example, increased expression of the protein has been observed in patients with liver disease, suggesting that it may play a role in the body's response to liver injury.
In addition, alterations in the function of the ghrelin receptor due to changes in the levels of Β-LGND2 have been implicated in the development of obesity and metabolic syndrome.
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD